Skip to main content
Clinical Trials/ITMCTR2200005733
ITMCTR2200005733
Not Yet Recruiting
Phase 1

Study on biomechanical mechanism and efficacy evaluation of Wei's two-step seven method for treatment of lumbar disc herniation

The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Meet the diagnostic criteria, including clinical signs and imaging data, among which the diagnostic criteria of TCM: refer to the diagnostic criteria of LDH in the Diagnostic and Therapeutic Criteria of TCM Diseases and Syndromes; Western diagnostic criteria: refer to the relevant content of the Chinese expert consensus on the diagnosis and treatment of lumbar disc herniation.
  • 2\) Sign informed consent with date, promise to abide by the study procedure, and cooperate with the implementation of the whole process of the study.
  • 3\) Aged 18\-65\.
  • 4\) Agree to receive treatment and sign informed consent.

Exclusion Criteria

  • 1\) Unable to cooperate with the completion of data collection or incomplete data;
  • 2\) Patients with lumbar vertebrae fracture or local bone diseases such as tuberculosis and tumor;
  • 3\) Patients with serious primary diseases such as cardiovascular, liver, kidney or hematopoietic system, other autoimmune diseases, allergic diseases and acute or chronic infected persons;
  • 4\) Psychiatric patients, or women with severe menopausal symptoms;
  • 5\) Pregnant or lactating women;
  • 6\) Experimental studies of other therapies for this disease are under way within 2 weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials